Economics of treatments for male infertility

Urologic Clinics of North America

Volumn 29, Issue 4, 2002, Pages 841-853

  Shin, David ^a   Honig, Stanton C ^b,c,d  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^c YALE NEW HAVEN HOSPITAL   (United States)

^d Urology Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; CARNITINE; CHORIONIC GONADOTROPIN; FOLLITROPIN; LEVACECARNINE;

COST BENEFIT ANALYSIS; ECONOMIC ASPECT; FERTILIZATION IN VITRO; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; INTRACYTOPLASMIC SPERM INJECTION; MALE GENITAL SYSTEM; MALE INFERTILITY; PRIORITY JOURNAL; REIMBURSEMENT; REVIEW; VASECTOMY;

COST-BENEFIT ANALYSIS; HEALTH CARE COSTS; HUMANS; INFERTILITY, MALE; MALE; UNITED STATES;

EID: 0036867698     PISSN: 00940143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0094-0143(02)00078-2     Document Type: Review

References (46)

1. Van Voorhis BJ, Stovall DW, Allen BD, et al. Cost-effective treatment of the infertile couple. Fertil Steril 1998;70:995-1005.
2. Fischer MA, Khamel K, Nam RK, et al. Patterns of use of alternative therapies in male infertility patients. J Urol 2001;165:1436A.
3. Schlegel PN. Is assisted reproduction the optimal treatment for varicocele-associated male infertility? A cost-effective analysis. Urology 1997;49:435-40.
4. Comhaire F. Economic strategies in modern male subfertility treatment. Hum Reprod 1995;10S:103-6.
5. Penson DF, Palter SJ, Paltiel AD, et al. A cost-effectiveness analysis of treatment strategies for varicocele-related infertility. J Urol 2000;163:9A.
6. Marmar JL, Corson SL, Batzer FR, et al. Insemination data on men with varicoceles. Fertil Steril 1992;57:1084-90.
7. Cayan S, Kardioglu A, Erdemir F, et al. Can varicocelectomy significantly change the way couples use assisted reproductive technologies? J Urol 2001;165:1264A.
8. Liskin L, Pile JM, Quillin WF. Vasectomy-safe and simple. Popul Rep 1983;11:61-99.
9. Fenster H, McLoughlin MG. Vasovasostomy-microscopic versus macroscopic techniques. Arch Androl 1981;7:201-4.
10. Heidenreich A, Altmann P, Engelmann UH. Microsurgical vasovasostomy versus microsurgical epididymal sperm aspiration/testicular extraction of sperm combined with intracytoplasmic sperm injection. Eur Urol 2000;37:609-14.
11. Jequire AM. Is vasectomy of long-term benefit? Vasectomy related infertility: A major and costly medical problem. Hum Reprod 1998;13:1757-60.
12. Schlegel PN, Palermo GP, Goldstein M, et al. Testicular sperm extraction with intracytoplasmic sperm injection for nonobstructive azoospermia. Urology 1997;49:435-40.
13. Tournaye H, Devroey P, Liu J, et al. Microsurgical epididymal sperm aspiration and intracytoplasmic sperm injection: A new effective approach to infertility as a result of congenital bilateral absence of the vas deferens. Fertil Steril 1994;61:1045-51.
14. Van Steirteghem A. Outcome of assisted reproductive technology. N Engl J Med 1998;338:194-5.
15. Zumbe J, Beintker M, Denil J, et al. MESA and TESE: Experiences of the German section of urological microsurgery. Andrologia 1996;28(suppl 1):89-92.
16. Pavlovich CP, Schlegel PN. Fertility options after vasectomy: A cost-effectiveness analysis. Fertil Steril 1997;67:133-41.
17. Kolettis PN, Thomas Jr AJ. Vasoepididymostomy for vasectomy reversal: A critical assessment in the era of intracytoplasmic sperm injection. J Urol 1997;158:467-70.
18. Donovan Jr JF, DiBaise M, Sparks AET, et al. Comparison of microscopic epididymal sperm aspiration and intracytoplasmic sperm injection/in-vitro fertilization with repeat microscopic reconstruction following vasectomy: Is second attempt vas reversal worth the effort? Hum Reprod 1998;13:387-93.
19. Deck AJ, Berger RE. Should vasectomy reversal be performed in men with older female partners? J Urol 2000;163:105-6.
20. Silber SJ, Nagy Z, Devroey P, et al. The effect of female age and ovarian reserve on pregnancy rate in male infertility: Treatment of azoospermia with sperm retrieval and intracytoplasmic sperm injection. Hum Reprod 1997;12:2693.
21. Schill WB, Haidl G. Medical treatment of male infertility. In: Insler V, Lunenfeld B, editors. Infertility-Male and Female. 2nd Edition. New York (NY): Churchill Livingston; 1993. p. 575-622.
22. Finkel DM, Phillips JL, Snyder PJ. Stimulation of spermatogenesis by gonadotropins in men with hypogonadotropic hypogonadism. N Engl J Med 1985;313:651-5.
23. Pavlovich CP, Schlegel PN. Male infertility current treatment, costs, and effectiveness. In: Ball TB, editor. AUA Update Series, Lesson 22. Houston (TX); AUA Office of Education; 1999. p. 170-5.
24. Chelmow D, Penzias AS, Kaufman G, et al. Obstetrics: Costs of triple pregnancy. Am J Obstet Gynecol 1995;172:677-82.
25. Neumann PJ, Gharib SD, Weinstein MC. The cost of a successful delivery with in vitro fertilization. N Engl J Med 1994;331:239-43.
26. Schieve LA, Peterson HB, Meikle SF, et al. An evaluation of the multiple birth risk associated with in vitro fertilization in the United States. JAMA 1999;282:1832-8.
27. Guzick DS, Carson SA, Coutifaris C, et al. Efficacy of superovulation and intrauterine insemination in the treatment of infertility. N Engl J Med 1999;340:177-83.
28. Goverde AJ, McDonnell J, Vermeiden JPW, et al. Intrauterine insemination or in-vitro fertilisation in idiopathic subfertility and male subfertility: A randomised trial and cost-effectiveness analysis. Lancet 2000;355:13-8.
29. Philips Z, Barraza-Llorens M, Posnett J. Evaluation of the relative cost-effectiveness of treatments for infertility in the UK. Hum Reprod 2000;15:95-106.
30. Van Voorhis BJ, Barnett M, Sparks AET, et al. Effect of the total motile sperm count on the efficacy and cost-effectiveness of intrauterine insemination and in vitro fertilization. Fertil Steril 2001;75:661-8.
31. Ola B, Afnan M, Sharif K, et al. Should ICSI be the treatment of choice for all cases of in-vitro conception? Considerations of fertilization and embryo development, cost effectiveness and safety. Hum Reprod 2001;16:2485-90.
32. Bhattacharya S, Hamilton MPR, Shaaban M, et al. Conventional in-vitro fertilisation versus intracytoplasmic sperm injection for the treatment of non-male-factor infertility: A randomised controlled trial. Lancet 2001;357:2075-9.
33. Onel E, Honig SC. Office based microscopic epididymal sperm aspiration (MESA) vs. operating room-based MESA: Cost and success analysis. Fertil Steril 1997;68(Suppl):S187-8.
34. Levine LA, Lisek EW. Successful sperm retrieval by percutaneous epididymal and testicular sperm aspiration. J Urol 1998;159:437-40.
35. Nudell DM, Conaghan J, Pedersen RA, et al. The mini micro epididymal sperm aspiration for sperm retrieval: a study of urological outcomes. Hum Reprod 1998;13:1260-5.
36. Dewire DM, Thomas Jr AJ, Falk RM, et al. Clinical outcome and cost comparison of percutaneous embolization and surgical ligation of varicocele. J Androl 1994;15(Suppl):38S-42S.
37. Ficarra V, Zanon G, D'Amico S, et al. Percutaneous, laparoscopic and surgical treatment of idiopathic varicocele: Analysis of costs. Arch Ital Urol Androl 1998;70:57-64.
38. Johnson N, Tauber R. Financial analysis of antegrade scrotal sclerotherapy for men with varicoceles. Br J Urol 1996;77:129-32.
39. Winfield HN, Donovan JF. Laparoscopic varicocelectomy. Semin Urol 1992;10:152-60.
40. Enquist E, Stein BS, Sigman M. Laparoscopic versus subinguinal varicocelectomy: A comparative study. Fertil Steril 1994;61:1092-6.
41. Schrepferman CG, Carson MR, Sparks AET, et al. Need for sperm retrieval and cryopreservation at vasectomy reversal. J Urol 2001;166:1787-9.
42. Potts JM, Pasqualotto FF, Nelson D, et al. Patient characteristics associated with vasectomy reversal. J Urol 1999;161:1835-9.
43. Honig SC, Lipshultz LI, Jarow J. Significant medical pathology uncovered by a comprehensive male infertility evaluation. Fertil Steril 1994;62:1028-34.
44. Kolettis PN, Sabanegh ES. Significant medical pathology discovered during a male infertility evaluation. J Urol 2001;166:178-80.
45. Sharda NN, Kinsella TJ, Ritter MA. Adjuvant radiation versus observation: A cost analysis of alternate management schemes in early-stage testicular seminoma. J Clin Oncol 1996;14:2933-9.
46. Shibley L, Brown M, Schuttinga J, et al. Cisplatin based combination chemotherapy in the treatment of advanced-stage testicular cancer: Cost-benefit ratio. J Natl Cancer Inst 1990;82:186-92.